IV Containers
PVC-free, DEHP-free products help protect susceptible populations: critically ill male neonates, pregnant and lactating women, pediatric patients, adolescent boys, and chemotherapy patients. Animal toxicity studies indicate that the following organs are targeted: testes, liver and kidneys. Medications, such as Taxol, exacerbate DEHP leaching. Sorption risk from the presence of PVC can result in reduced levels of medication being delivered. 1 Bristol-Myers Squibb Company, Oncology Division. Taxol (Paclitaxel) Injection Administration, Equipment, 11/99 EquipmentEnvironmental Safety
Patient Safety
Products that exacerbate leaching:
The following drugs adsorb to PVC medical products:2,3
2 Chemical and Physical Compatibility of Selected Drugs in EXCEL® Container System
3 Glass and Accumed™ IV Delivery Systems Drug Additive and Chemical Physical Compatibility Guide


